Home RxNorm 1291103 hydrocortisone acetate 25 MG Rectal Suppository [Anusol HC] Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 1291103
RxNorm name hydrocortisone acetate 25 MG Rectal Suppository [Anusol HC]
Display name ANUSOL HC (Rectal)
Full name hydrocortisone acetate 25 MG Rectal Suppository [Anusol HC]
Term type SBD
Status Active
Strength 25 mg
Dose form Suppository
Route Rectal
Updated 2026-07-20 06:52:43 RxNorm Status History#
Status Active
Source RXNORM
Current YES
Release start 062012
Active start 062012
Multiple ingredient NO
Branded YES Ingredients And Strength# Ingredient, Strength, Base table Ingredient Strength Base Basis of strength hydrocortisone acetate 25 MG / 1 EACH hydrocortisone hydrocortisone acetate
Derived Ingredient Concepts# FDA NDC Products And Packages# Package NDC, Product NDC, Name table Package NDC Product NDC Name Labeler Application 65649-411-12 65649-411 Anusol HC HYDROCORTISONE ACETATE Salix Pharmaceuticals, Inc 65649-411-24 65649-411 Anusol HC HYDROCORTISONE ACETATE Salix Pharmaceuticals, Inc
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 10 matching rows.
NDC11, Source, Active table NDC11 Source Active 65649041112 rxnav_ndcs yes 65649041124 rxnav_ndcs yes 00071172607 rxnav_historical_indirect 00071172613 rxnav_historical_indirect 60793090361 rxnav_historical_indirect 60793090362 rxnav_historical_indirect 61570017261 rxnav_historical_indirect 61570017262 rxnav_historical_indirect 61570030361 rxnav_historical 61570030362 rxnav_historical
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Set ID, RxNorm string, TTY table Set ID RxNorm string TTY SPL version Label Effective a562f3d7-2692-4357-aade-ae50afcbfddd Anusol HC 25 MG Rectal Suppository SY 7 Anusol-HC ® Hydrocortisone Acetate Rectal Suppositories, 25 mg Rx only 20240701 a562f3d7-2692-4357-aade-ae50afcbfddd Anusol-HC 25 MG Rectal Suppository PSN 7 Anusol-HC ® Hydrocortisone Acetate Rectal Suppositories, 25 mg Rx only 20240701 a562f3d7-2692-4357-aade-ae50afcbfddd hydrocortisone acetate 25 MG Rectal Suppository [Anusol HC] SBD 7 Anusol-HC ® Hydrocortisone Acetate Rectal Suppositories, 25 mg Rx only 20240701
Drug Classes# Source, Class ID, Class table Source Class ID Class Type Relationship Drug concept ATC S02BA Corticosteroids ATC1-4 hydrocortisone ATC C05AA Corticosteroids ATC1-4 hydrocortisone ATC A07EA Corticosteroids acting locally ATC1-4 hydrocortisone ATC A01AC Corticosteroids for local oral treatment ATC1-4 hydrocortisone ATC S01BA Corticosteroids, plain ATC1-4 hydrocortisone ATC D07AA Corticosteroids, weak (group I) ATC1-4 hydrocortisone ATC D07XA Corticosteroids, weak, other combinations ATC1-4 hydrocortisone ATC S01CB Corticosteroids/antiinfectives/mydriatics in combination ATC1-4 hydrocortisone ATC H02AB Glucocorticoids ATC1-4 hydrocortisone FDASPL N0000175576 Corticosteroid EPC has_epc hydrocortisone MEDRT D006854 Hydrocortisone CHEM has_ingredient hydrocortisone MEDRT D006854 Hydrocortisone CHEM has_ingredient hydrocortisone acetate MEDRT D000312 Adrenal Hyperplasia, Congenital DISEASE may_treat hydrocortisone acetate MEDRT D000312 Adrenal Hyperplasia, Congenital DISEASE may_treat hydrocortisone MEDRT D000309 Adrenal Insufficiency DISEASE may_treat hydrocortisone acetate MEDRT D000309 Adrenal Insufficiency DISEASE may_treat hydrocortisone MEDRT D003093 Colitis, Ulcerative DISEASE may_treat hydrocortisone acetate MEDRT D003093 Colitis, Ulcerative DISEASE may_treat hydrocortisone MEDRT D003877 Dermatitis, Contact DISEASE may_treat hydrocortisone acetate MEDRT D003877 Dermatitis, Contact DISEASE may_treat hydrocortisone MEDRT D003881 Dermatomycoses DISEASE ci_with hydrocortisone acetate MEDRT D003881 Dermatomycoses DISEASE ci_with hydrocortisone MEDRT D004342 Drug Hypersensitivity DISEASE ci_with hydrocortisone acetate MEDRT D004342 Drug Hypersensitivity DISEASE ci_with hydrocortisone MEDRT D005148 Facial Dermatoses DISEASE may_treat hydrocortisone acetate MEDRT D005148 Facial Dermatoses DISEASE may_treat hydrocortisone MEDRT D005533 Foot Dermatoses DISEASE may_treat hydrocortisone acetate MEDRT D005533 Foot Dermatoses DISEASE may_treat hydrocortisone MEDRT D006229 Hand Dermatoses DISEASE may_treat hydrocortisone acetate MEDRT D006229 Hand Dermatoses DISEASE may_treat hydrocortisone MEDRT D006484 Hemorrhoids DISEASE may_treat hydrocortisone acetate MEDRT D006484 Hemorrhoids DISEASE may_treat hydrocortisone MEDRT D007249 Inflammation DISEASE may_treat hydrocortisone acetate MEDRT D007249 Inflammation DISEASE may_treat hydrocortisone MEDRT D007868 Leg Dermatoses DISEASE may_treat hydrocortisone MEDRT D007868 Leg Dermatoses DISEASE may_treat hydrocortisone acetate MEDRT D011538 Pruritus Ani DISEASE may_treat hydrocortisone acetate MEDRT D011538 Pruritus Ani DISEASE may_treat hydrocortisone MEDRT D012216 Rheumatic Diseases DISEASE may_treat hydrocortisone acetate MEDRT D012216 Rheumatic Diseases DISEASE may_treat hydrocortisone MEDRT D012536 Scalp Dermatoses DISEASE may_treat hydrocortisone acetate MEDRT D012536 Scalp Dermatoses DISEASE may_treat hydrocortisone MEDRT D012769 Shock DISEASE may_treat hydrocortisone MEDRT D012769 Shock DISEASE may_treat hydrocortisone acetate MEDRT D012876 Skin Diseases, Parasitic DISEASE ci_with hydrocortisone MEDRT D012876 Skin Diseases, Parasitic DISEASE ci_with hydrocortisone acetate MEDRT D017193 Skin Diseases, Viral DISEASE ci_with hydrocortisone MEDRT D017193 Skin Diseases, Viral DISEASE ci_with hydrocortisone acetate MEDRT D013224 Status Asthmaticus DISEASE may_treat hydrocortisone acetate MEDRT D013224 Status Asthmaticus DISEASE may_treat hydrocortisone MEDRT D014382 Tuberculosis, Cutaneous DISEASE ci_with hydrocortisone MEDRT D014382 Tuberculosis, Cutaneous DISEASE ci_with hydrocortisone acetate MEDRT N0000000159 Glucocorticoid Receptor Agonists MOA has_moa hydrocortisone acetate MEDRT N0000000159 Glucocorticoid Receptor Agonists MOA has_moa hydrocortisone MEDRT N0000000134 Lipoxygenase Inhibitors MOA has_moa hydrocortisone MEDRT N0000000134 Lipoxygenase Inhibitors MOA has_moa hydrocortisone acetate MEDRT N0000008327 Carbohydrate Metabolism Alteration PE has_pe hydrocortisone acetate MEDRT N0000008327 Carbohydrate Metabolism Alteration PE has_pe hydrocortisone MEDRT N0000010253 Decreased Capillary Permeability PE has_pe hydrocortisone acetate MEDRT N0000010253 Decreased Capillary Permeability PE has_pe hydrocortisone MEDRT N0000010248 Decreased Fibroblast Migration PE has_pe hydrocortisone acetate MEDRT N0000010248 Decreased Fibroblast Migration PE has_pe hydrocortisone MEDRT N0000008645 Decreased Glucocorticoid Secretion PE has_pe hydrocortisone acetate MEDRT N0000008645 Decreased Glucocorticoid Secretion PE has_pe hydrocortisone MEDRT N0000008681 Decreased Leukotriene Activity PE has_pe hydrocortisone MEDRT N0000008681 Decreased Leukotriene Activity PE has_pe hydrocortisone acetate MEDRT N0000008700 Decreased Lysosomal Function PE has_pe hydrocortisone acetate MEDRT N0000008700 Decreased Lysosomal Function PE has_pe hydrocortisone MEDRT N0000010246 Decreased Polymorphonuclear Leukocyte Migration PE has_pe hydrocortisone acetate MEDRT N0000010246 Decreased Polymorphonuclear Leukocyte Migration PE has_pe hydrocortisone MEDRT N0000008834 Decreased Prostaglandin Activity PE has_pe hydrocortisone acetate MEDRT N0000008834 Decreased Prostaglandin Activity PE has_pe hydrocortisone MEDRT N0000008841 Decreased Protein Synthesis PE has_pe hydrocortisone MEDRT N0000008841 Decreased Protein Synthesis PE has_pe hydrocortisone acetate MEDRT N0000009004 Decreased Thromboxane Activity PE has_pe hydrocortisone MEDRT N0000009004 Decreased Thromboxane Activity PE has_pe hydrocortisone acetate MEDRT N0000009739 Lipid Metabolism Alteration PE has_pe hydrocortisone MEDRT N0000009739 Lipid Metabolism Alteration PE has_pe hydrocortisone acetate
Properties# Category, Property, Value table Category Property Value ATTRIBUTES AVAILABLE_STRENGTH 25 MG (expressed as hydrocortisone acetate) ATTRIBUTES GENERAL_CARDINALITY SINGLE ATTRIBUTES HUMAN_DRUG US ATTRIBUTES PRESCRIBABLE Y ATTRIBUTES RXNAV_HUMAN_DRUG US ATTRIBUTES SCHEDULE 0 ATTRIBUTES TTY SBD CODES MMSL_CODE BD271 CODES RxCUI 1291103 CODES SPL_SET_ID a562f3d7-2692-4357-aade-ae50afcbfddd NAMES Prescribable Synonym Anusol-HC 25 MG Rectal Suppository NAMES RXNAV_STR Anusol HC 25 MG Rectal Suppository NAMES RxNorm Name hydrocortisone acetate 25 MG Rectal Suppository [Anusol HC] NAMES RxNorm Synonym Anusol HC 25 MG Rectal Suppository SOURCES Source Gold Standard Alchemy SOURCES Source Metathesaurus FDA Structured Product Labels SOURCES Source Micromedex RED BOOK SOURCES Source Multum MediSource Lexicon